Michigan will be the team to beat next season.

Completed End-of-Phase 2 meeting with the FDA; Company expects to provide a regulatory update in early 2Q 2026 and remains on track to initiate a ...

Net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. -- Selling, general and administrative ("SG&A") expenses were $241.5 million for ...

Avoid high-yield “mousetrap” REITs: weak Dividend Safety, high payout ratios and debt signal cut risk and losses. Read here ...